Sign Up to like & get
recommendations!
1
Published in 2017 at "Cancer Cytopathology"
DOI: 10.1002/cncy.21917
Abstract: Malignant mesothelioma (MM) is an aggressive, fatal tumor. Current therapeutic options only marginally improve survival. Programmed cell death ligand 1 (PD‐L1) is a dominant mediator of immunosuppression, binding to programmed cell death 1 (PD‐1). PD‐L1…
read more here.
Keywords:
immuno cytochemical;
mesothelioma immuno;
expression;
determination expression ... See more keywords